TAILIEUCHUNG - Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens

Flow cytometry (FC) is a popular method to detect bone marrow (BM) involvement in patients with B-cell non-Hodgkin lymphoma (B-NHL). The majority of screen panels of FC still rely on finding monoclonal B-cells, ., B-cells with immunoglobin (Ig) light-chain restriction, which has many limitations. Therefore, exploring new markers is warranted. | Wang et al. BMC Cancer 2021 21 1315 https s12885-021-09061-3 RESEARCH Open Access Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens Wei Wang1 Yan Li2 Haval Ali1 Linjun Zhao3 Di Mei3 Wenqing Hu2 and Bin Jiang2 Abstract Background Flow cytometry FC is a popular method to detect bone marrow BM involvement in patients with B-cell non-Hodgkin lymphoma B-NHL . The majority of screen panels of FC still rely on finding monoclonal B-cells . B-cells with immunoglobin Ig light-chain restriction which has many limitations. Therefore exploring new mark- ers is warranted. Methods A total of 52 cases of B-NHL with BM involvement were collected. The median age was 60 years. Out of these 52 cases 34 were male and 18 were female. A 10-color FC panel was used to detect the expression of CD54 on lymphoma cells. The expression of CD54 was calculated as the mean fluorescence index ratio MFIR and was described as the mean standard error of the mean SEM . Results Up to 18 52 of BM specimens abnormally expressed an increased level of CD54 including 1 10 cases of chronic lymphocytic leukemia small lymphocytic lymphoma CLL SLL 9 13 cases of mantle cell lymphoma MCL 2 14 cases of follicular lymphoma FL 5 9 cases of marginal zone lymphoma MZL and 1 3 cases of high- grade B-NHL HG B-NHL . The expression level of CD54 was significantly increased in MCL cases com- pared with CLL SLL cases and FL cases . The lowest percentage of CD54-positive B-cells attained . In 5 9 cases of MZL and 1 3 cases of HG B-NHL increased expression of CD54 was the only abnormal immunophenotype detected besides Ig light-chain restriction. No aberrant CD54 expression was identified by FC in lymphoplasmacytic lymphoma LPL 0 2 and Burkitt lymphoma BL 0 1 cases. Aberrant expression of CD54 was not related to plasma cell differentiation. Conclusion Lymphoma cells especially in MCL and MZL .

• Y khoa - Dược
• BMC Cancer
• Flow cytometry
• B cell non Hodgkin lymphoma
• Bone marrow involvement
• Burkitt lymphoma
• Marginal zone lymphoma
• Cancer patient pathways
• Colorectal cancer
• Lung cancer
• Breast cancer
• Prostate cancer
• Ovarian cancer
• Cancer detection
• Ovarian cancer symptoms
• Ovarian cancer signs
• Ovarian cancer tests
• Cancer biomarkers
• Pediatric cancer
• Familial cancer predisposition
• Hereditary cancer syndrome
• Genetic cancer susceptibility
• Advanced cancer
• Biliary tract cancer
• Multimodal intervention
• Pancreatic cancer
• Physical activity
• Breast cancer screening
• Familial breast cancer
• Young breast cancer survivors
• High risk relatives
• Randomized trial
• Childhood cancer
• Childhood cancer survivor
• Thyroid cancer screening
• Secondary cancer
• Cancer screening
• Community awareness
• Cancer education
• Cervical cancer
• Prior cancer
• Cancer survivors
• Cancer registry
• Second cancer
• Surgical oncology
• Cancer imaging
• Radiation oncologists
• Medical oncologists
• Oesophagogastric cancer
• Liver cancer
• Hepatobiliary cancer
• Multidisciplinary rehabilitation
• EGFR mutation
• Family history of cancer
• Inherited susceptibility
• Cancer predisposition genes
• Lung cancer aetiology
• Cancer stem cells
• Oct4 overexpressing lung cancer
• Human lung cancer xenograft model
• Disease free survivals
• Cancer hallmarks
• Cancer genesis
• Defiant disease
• Mutational signature
• Cancer diagnosis
• Cancer genomics
• Molecular medicine
• Whole genome sequencing
• Cancer susceptibility gene
• Breast cancer prognosis
• Next generation sequencing
• Quality of care
• Quality indicators
• Shifting cancer care
• German cancer society
• Colorectal cancer screening
• Stomach cancer screening
• Lung cancer survivor
• Physician recommendation
• Total number of lymph nodes
• Lymph node ratio
• Left colon cancer
• Right colon cancer
• Overall survival
• Cumulative incidence
• Esophageal cancer
• Head and neck cancer
• Metachronous cancer
• Young onset
• Reproductive cancer
• Risk factor
• Early detection of cancer
• Gastric cancer incidence
• Population based specialized registry
• Gastric cancer survival
• Gastric cancer clinical characteristics
• Gastric cancer pathological characteristics
• Lung Cancer Screening
• Racial disparities
• Lung Cancer diagnosis
• Screening adherence
• Second primary colorectal cancer
• Standardized incidence ratio
• Left sided colon cancer
• Right sided colon cancer
• Quality of cancer care
• Population based study